CHINA-BEIJING-CIFTIS-VENUE (CN)

CHINA-BEIJING-CIFTIS-VENUE (CN)

(220828) -- BEIJING, Aug. 28, 2022 (Xinhua) -- Photo taken on Aug. 28, 2022 shows the booth of the China National Biotec Group (CNBG) during a media preview of the 2022 China International Fair for Trade in Services (CIFTIS) at the China National Convention Center in Beijing, capital of China. The 2022 CIFTIS will be held at the China National Convention Center and the Shougang Park in Beijing from Aug. 31 to Sept. 5. (Xinhua/Cai Yang)

Myanmar starts administering locally produced Sinopharm COVID-19 vaccines

STORY: Myanmar starts administering locally produced Sinopharm COVID-19 vaccines DATELINE: May 5, 2022 LENGTH: 00:04:57 LOCATION: Yangon CATEGORY: HEALTH SHOTLIST: 1. various of the launching ceremony STORYLINE: Myanmar has begun administering locally filled-and-packed doses of China's Sinopharm COVID-19 vaccines, locally known as the Myancopharm vaccines, according to the Ministry of Health on Thursday. "The inoculation of Myancopharm COVID-19 vaccines has begun not only in Nay Pyi Taw and Yangon but also in other regions and states," Than Naing Soe, a director from the Ministry of Health, told Xinhua on Thursday. Union Minister for Health Thet Khaing Win observed the administering of Myancopharm COVID-19 vaccines in Nay Pyi Taw on Wednesday. Myanmar's Ministry of Industry, in collaboration with China National Biotec Group (CNBG), affiliated with Sinopharm, domestically packed and produced the Myancopharm COVID-19 vaccines. The health ministry said it received a total of 1 million doses o

Myanmar, China jointly produce COVID-19 vaccines

STORY: Myanmar, China jointly produce COVID-19 vaccines DATELINE: March 24, 2022 LENGTH: 00:03:24 LOCATION: YANGON, Myanmar CATEGORY: SOCIETY/HEALTH SHOTLIST: 1. various of the signature ceremony of Myanmar, China cooperation 2. various of the production line of COVID-19 vaccines STORYLINE: Myanmar launched the production of Myancopharm COVID-19 vaccines in Yangon on Wednesday at Myanmar Pharmaceutical Industry (MPI) in collaboration with China. Lt.-Gen. Aung Lin Dwe, secretary of the State Administration Council (SAC), said Myanmar has trialed and produced COVID-19 vaccines domestically in cooperation with Sinopharm CNBG. "Technology for vaccine production was obtained and foreign currency use would be reduced as Myancopharm COVID-19 vaccines were successfully produced in the country," he said. Chinese Ambassador Chen Hai said Sinopharm's cooperative Ready to Fill (RTF) Bulk vaccine plant with Myanmar is the Chinese pharmaceutical company's first COVID-19 vaccine plant officially put into operation in